Teladoc Health, Inc. (NYSE:TDOC) COO Michael Willem Waters Sells 5,793 Shares

Teladoc Health, Inc. (NYSE:TDOC) COO Michael Willem Waters sold 5,793 shares of the stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $73,513.17. Following the transaction, the chief operating officer now owns 64,881 shares in the company, valued at $823,339.89. The sale was disclosed in a filing with the SEC, which is available through this link.

Michael Willem Waters also recently made the following trade(s):

• On Friday, February 2nd, Michael Willem Waters sold 4,523 shares of Teladoc Health stock. The stock was sold at an average price of $19.18, for a total transaction of $86,751.14.

Teladoc Health Stock Performance

Shares of NYSE:TDOC traded up $0.18 during trading on Thursday, hitting $13.00. 5,025,101 shares of the stock traded hands, compared to its average volume of 4,835,000. The company has a fifty day moving average price of $14.48 and a two-hundred day moving average price of $17.60. The company has a quick ratio of 3.47, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. The company has a market cap of $2.20 billion, a price-to-earnings ratio of -9.08 and a beta of 0.97. Teladoc Health, Inc. has a 52-week low of $12.53 and a 52-week high of $30.41.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The firm had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The company’s revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.37) EPS. As a group, equities analysts predict that Teladoc Health, Inc. will post -1.04 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Parallel Advisors LLC increased its position in shares of Teladoc Health by 14.6% during the fourth quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock valued at $87,000 after acquiring an additional 515 shares during the last quarter. M&T Bank Corp increased its position in shares of Teladoc Health by 5.5% during the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider’s stock valued at $241,000 after acquiring an additional 584 shares during the last quarter. Van ECK Associates Corp increased its position in shares of Teladoc Health by 20.3% during the fourth quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock valued at $77,000 after acquiring an additional 606 shares during the last quarter. Arizona State Retirement System increased its position in shares of Teladoc Health by 1.4% during the third quarter. Arizona State Retirement System now owns 46,602 shares of the health services provider’s stock valued at $866,000 after acquiring an additional 650 shares during the last quarter. Finally, Victory Capital Management Inc. increased its position in shares of Teladoc Health by 4.3% during the third quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider’s stock valued at $334,000 after acquiring an additional 748 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. DA Davidson lowered their target price on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Citigroup lowered their target price on shares of Teladoc Health from $21.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Truist Financial lowered their target price on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating for the company in a research note on Wednesday, March 6th. Wells Fargo & Company lowered their target price on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating for the company in a research note on Monday. Finally, Canaccord Genuity Group decreased their price objective on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, April 26th. Twelve analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $18.73.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.